Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

Adam Croft appointed Norman Collisson Professor of Musculoskeletal Science

This appointment brings a further focus to linking rheumatology discovery science and clinical trials in NDORMS, strengthening translational rheumatology research across the department to deliver transformative treatments for patients with inflammatory arthritis.

Ghada Alsaleh awarded an Arthritis UK Bridging Fellowship

Professor Ghada Alsaleh has been awarded an Arthritis UK Bridging Fellowship to advance her work studying potential osteoarthritis (OA) treatments.

Arthritis origins may begin before birth, study finds

Researchers at the Kennedy Institute have discovered that some joints may be more susceptible to inflammatory arthritis before birth, offering new insight into why rheumatoid arthritis attacks particular joints while sparing others.

Largest study of knee osteoarthritis tissue reveals the core biological pathways underlying osteoarthritis

A major international study led by researchers at the Kennedy Institute of Rheumatology at the University of Oxford has found that osteoarthritis (OA) – the most common form of arthritis worldwide – is not a collection of separate diseases, as many scientists had previously speculated, but rather a single condition with common core underlying biological pathways.

£3M study led by patient voices targets pain in inflammatory arthritis

Researchers across the UK are banding together to tackle one of the largest unmet clinical needs in inflammatory arthritis, pain reduction, in a new £3m research programme funded by Arthritis UK.

Kennedy scientists join world-leading researchers in ‘pivotal’ study to help arthritis patients to live drug free

The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer to becoming a reality, thanks to a new collaboration.

World-leading researchers unite for ‘pivotal’ study to help children and adults with arthritis to live drug free

The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer to becoming a reality, thanks to a new collaboration which includes world-leading researchers from the Kennedy Institute.

Two NDORMS groups join the PROBE Initiative to advance osteoarthritis research

Two research groups at NDORMS have joined the newly launched PROBE initiative, contributing their expertise to a major European collaboration focused on improving the understanding, diagnosis and treatment of osteoarthritis.

First of its kind study for children with arthritis reveals possible new disease targets

Researchers have been able to see what happens in the inflamed joints of children with arthritis, giving insight into why treatments affect children differently.

New insights into chronic inflammation in rheumatoid arthritis

Kennedy researchers have uncovered new clues about how immune memory exacerbates inflammation in rheumatoid arthritis, which could lead to better ways to control the disease.

Psoriatic arthritis: hit hard and early

Laura Coates presents the results from the 'SPEED' trial that found early use of biologic therapy or combination conventional DMARDs may be more effective than standard step-up care with methotrexate for psoriatic arthritis patients with poor prognostic factors.

New research identifies key driver of inflammation in spondyloarthritis

NDORMS researchers have identified a primary source of inflammatory IL-17 driving spondyloarthritis, paving the way for the development of targeted therapies to treat the condition.

Laura Coates becomes the first rheumatologist to receive prestigious NIHR professorship

The first ever rheumatologist to be awarded an NIHR Research Professorship, Laura will use the funding to further her research into psoriasis and psoriatic arthritis aiming to transform patient care and treatment personalisation.

World Arthritis Day 2024 - Empowering patients in rheumatology

To mark World Arthritis Day, the British Society for Rheumatology has announced the launch of a new toolkit that will help patients take more control of their arthritis treatment.

Psoriasis probe shows high level of arthritis symptoms in patients

Early results of an international study examining the risk of arthritis for people with psoriasis have shown a high burden of joint symptoms in 712 patients – 25% of the total studied so far.

Botnar researchers awarded Fellowships

Arani Vivekanantham has been awarded an NIHR Doctoral Fellowship and a Versus Arthritis Clinical Research Fellowship, and Rachel Kuo was awarded an NIHR Doctoral Research Fellowship.

Better diagnosis and treatment of autoimmune diseases moves a step closer

A study published in Nature outlines a way to find the crucial peptides (protein fragments) that drive autoimmunity, as well as the immune cells that respond to them.

NDORMS and GRAPPA launch new resource to help people suffering from psoriatic arthritis

NDORMS and GRAPPA (the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) have launched Informatree, a new web resource to help people living with Psoriatic Arthritis.

New funding awarded to study persistent pain in inflammatory arthritis

The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.

New research reveals link between ankle pain and onset of knee osteoarthritis

A new study published in Osteoarthritis and Cartilage Open could help improve the lives of people at risk of developing knee osteoarthritis.

Load More